Ganirelix Acetate Injection, Solution
Product Images NDC 83301-0082

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ganirelix Acetate (NDC 83301-0082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ganirelix 01)

FDA Label Image

Principal Display Panel (250 mcg/0.5 mL Syringe Carton)

Principal Display Panel (250 mcg/0.5 mL Syringe Carton)
Each 1 mL syringe contains 250 mcg/0.5 mL of ganirelix acetate, along with 0.1 mg of glacier acetic acid, 23.5 mg of mannitol, and water for injection. The solution is adjusted to pH 5.0 using acetic acid and/or sodium hydroxide. This is a subcutaneous injection used per enclosed prescribing information. The storage temperature recommended is 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The product is packaged in a single-dose sterile prefilled syringe with a 27-gauge needle. The packaging components are free from dry natural rubber/latex. The NDC number for this product is 83301-0082-1, and it is for prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.